ANI Pharmaceuticals, Inc. (BST:BSFA)

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,367	1,405	1,043	952	614	678
Market Cap Growth	21.06%	34.81%	9.52%	55.11%	-9.53%	138.20%
Enterprise Value	1,673	1,712	1,529	1,063	855	850
Last Close Price	65.00	68.00	51.00	48.60	37.60	40.80
PE Ratio	20.80	21.38	-	68.00	-	-
PS Ratio	1.82	1.87	1.76	2.16	2.07	3.57
PB Ratio	2.97	3.05	2.52	2.30	1.94	2.15
P/TBV Ratio	-	-	-	5.38	19.39	64.94
P/FCF Ratio	9.37	9.63	22.59	9.56	-	1008.43
P/OCF Ratio	8.67	8.91	16.86	8.85	-	232.23
EV/Sales Ratio	2.23	2.28	2.58	2.41	2.89	4.47
EV/EBITDA Ratio	11.43	11.64	19.23	10.75	26.93	50.64
EV/EBIT Ratio	24.29	24.75	108.31	23.73	-	-
EV/FCF Ratio	11.46	11.73	33.14	10.67	-	1263.31
Debt / Equity Ratio	1.14	1.14	1.47	0.62	0.85	0.80
Debt / EBITDA Ratio	3.57	3.57	7.44	2.61	8.26	15.06
Debt / FCF Ratio	3.60	3.60	13.20	2.60	-	375.65
Net Debt / Equity Ratio	0.60	0.60	1.12	0.14	0.71	0.52
Net Debt / EBITDA Ratio	1.87	1.87	5.82	0.59	7.07	9.80
Net Debt / FCF Ratio	1.88	1.88	10.04	0.59	-5.98	244.54
Asset Turnover	0.65	0.65	0.56	0.59	0.41	0.35
Inventory Turnover	2.44	2.44	2.02	1.68	1.48	1.41
Quick Ratio	2.07	2.07	1.93	2.63	2.15	2.61
Current Ratio	2.71	2.71	2.73	3.57	3.46	3.68
Return on Equity (ROE)	16.16%	16.16%	-4.18%	4.72%	-13.74%	-15.37%
Return on Assets (ROA)	3.73%	3.73%	0.83%	3.72%	-2.10%	-2.86%
Return on Invested Capital (ROIC)	7.68%	7.50%	2.04%	8.51%	-4.58%	-6.04%
Return on Capital Employed (ROCE)	7.00%	7.00%	1.30%	6.50%	-3.90%	-4.10%
Earnings Yield	4.81%	4.75%	-1.72%	1.79%	-7.30%	-5.52%
FCF Yield	10.68%	10.39%	4.43%	10.46%	-6.11%	0.10%
Payout Ratio	1.48%	1.48%	-	8.65%	-	-
Buyback Yield / Dilution	-9.89%	-9.89%	-6.18%	-11.89%	-29.09%	-5.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.